Trial intelligence / Profile preview

Low molecular weight heparin versus unfractionated heparin for cerebral venous sinus thrombosis

IRCT201102241856N3Phase 2Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Dec 2013
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2 trial of low molecular weight heparin calcium and heparin in cerebral sinovenous thrombosis (CSVT) (2 arms), sponsored by Kermanshah University of Medical Sciences. Started Dec 2013; status: completed.

02

Drugs

low molecular weight heparin calciumheparin
03

Conditions

cerebral sinovenous thrombosis (CSVT)

Beyond the preview

Go deeper on IRCT201102241856N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201102241856N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call